An elastase-dependent pathway of plasminogen activation

Area of Science:

• Biochemistry
• Molecular Biology
• Hemostasis and Thrombosis

Background:

• Plasminogen activation is crucial for fibrinolysis.
• Alpha 2-antiplasmin is a primary inhibitor of plasmin.
• Elastase's role in plasminogen activation is not fully understood.

Purpose of the Study:

• To investigate the effect of pancreatic and leukocyte elastase on plasminogen activation.
• To elucidate the mechanisms by which elastase influences fibrinolysis.
• To determine if elastase can overcome inhibition by alpha 2-antiplasmin.

Main Methods:

• In vitro reactions with purified Glu-plasminogen, alpha 2-antiplasmin, and plasminogen activators (tPA or urokinase).
• Enzymatic assays to measure plasminogen activation rates and inhibitor kinetics.
• Degradation studies of plasminogen and alpha 2-antiplasmin by elastase.

Main Results:

• Elastase enhanced plasminogen activation by over two orders of magnitude.
• Elastase degraded plasminogen to des-kringle1-4-plasminogen (mini-plasminogen), a more efficient substrate.
• Mini-plasminogen showed reduced sensitivity to inhibitors.
• Elastase efficiently inhibited alpha 2-antiplasmin.
• Elastase suppressed endogenous inhibitor capacity in plasma.

Conclusions:

• Elastase significantly promotes plasminogen activation and fibrinolysis.
• Elastase acts via plasminogen modification and direct inhibition of alpha 2-antiplasmin.
• Elastases represent an alternative pathway for plasminogen activation.
• Elastase may regulate fibrinolysis initiation by urokinase-type plasminogen activators.